Aberrant behaviors and Co-occurring conditions as predictors of psychotropic polypharmacy among children with autism spectrum disorders

Journal of Child and Adolescent Psychopharmacology

Volumn 25, Issue 4, 2015, Pages 323-336

  Logan, Sarah L ^a   Carpenter, Laura ^b   Leslie, R Scott ^c   Garrett Mayer, Elizabeth ^b   Hunt, Kelly J ^b   Charles, Jane ^b   Nicholas, Joyce S ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Centra Neuroscience Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AGGRESSION; ANGER; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; AUTOMUTILATION; BEHAVIOR DISORDER; CHILD; CHILD PSYCHIATRY; COMMUNICATION DISORDER; COMPARATIVE STUDY; CONDUCT DISORDER; CONTROLLED STUDY; EATING DISORDER; FEMALE; FOSTER CARE; HUMAN; HYPERACTIVITY; ICD-9; IMPULSIVENESS; INTELLECTUAL IMPAIRMENT; LEARNING DISORDER; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAID; MOOD DISORDER; OPPOSITIONAL DEFIANT DISORDER; POLYPHARMACY; RACE DIFFERENCE; SCHOOL CHILD; SEIZURE; SLEEP DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; CHILD BEHAVIOR DISORDERS; PSYCHOLOGY;

ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; CHILD; CHILD BEHAVIOR DISORDERS; FEMALE; HUMANS; MALE; MEDICAID; POLYPHARMACY; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 84929576418     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0119     Document Type: Article

References (46)

1. Aman MG, Lam K S L, Van Bourgondien ME: Medication patterns in patients with autism: Temporal, regional, and demographic influences. J Child Adolesc Psychopharmacol 15:116-126, 2005.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. Bilder D, Pinborough-Zimmerman J, Miller J, McMahon W: Prenatal, perinatal, and Neonatal factors associated with autism spectrum disorders. Pediatrics 123:1293-1300, 2009.
4. Centers for Disease Control: Prevalence of autism spectrum disorders - ADDM network, United States, 2006. MMWR Morb Mortal Wkly Rep 56:1-28, 2009.
5. Centers for Disease Control: "Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Morb Mortal Wkly Rep 61:1-19, 2012.
6. Charles JM, Carpenter LA, Jenner W, Nicholas JS: Recent advances in autism spectrum disorders. Int J Psychiatry Med 38:133-140, 2008.
7. Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, Donaldson A, Varley J: Randomized, controlled trial of an intervention for toddlers with autism: The Early Start Denver Model. Pediatrics 125:e17-23, 2010.
8. dos Reis S, Yooun Y, Riddle M, Noll E, Rothbard A: Antipsychotic treatment among youth in foster care. Pediatrics 128:e1459-e1466, 2011.
9. dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL: Multiple psychotropic medication use for youths: A two-state comparison. J Child Adolesc Psychopharmacol 15:68-77, 2005.
10. Durkin M, Meaney F, Levy SE, Di Guiseppi C, Nicholas JS, Kirby RS, Pinto-Martin J, Shieve L: Socioeconomic inequality in the prevalence of autism spectrum disorder: Evidence from a US crosssectional study. PLoS ONE 5:e11551, 2010.
11. Durkin MS, Newschaffer CJ, Lee LC, Cunniff CM, Daniels JL, Kirby RS, Leavitt L, Miller L, Zahorodny W, Schieve LA: Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 168:1268-1276, 2008.
12. Erickson CA, Posey DJ, Stigler KA, McDougle CJ: Pharmacologic treatment of autism and related disorders. Pediatr Ann 36:575-585, 2007.
13. Esbensen A, Greenberg J, Seltzer MM, Aman MG: A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. J Autism Dev Disor 39:1339-1349, 2009.
14. Johnson CP, Myers SM, American Academy of Pediatrics Council on Children with Disabilities: Identification and evaluation of children with autism spectrum disorders. Pediatrics 120:1183-1215, 2007.
15. Kalkbrenner AE, Chen JC, Poole C, Emch M, Morrissey J: Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology 21:631-641, 2010.
16. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 46:1125-1133, 2008.
17. King LB, Nicholas JS, Carpenter LA, Jenner WH, Charles JM: Characteristics of autism spectrum disorders over time, surveillance results from children born between 1992 and 2002. AEP 18, 2008.
18. Levy S, Giarelli E, Lee LC, Schieve LA, Kirby RS, Cunniff C, Nicholas J, Reaven J, Rice CE: Autism spectrum disorder and cooccurring developmental, psychiatric, medical conditions among children in multiple populations of the United States. J Dev Behav Pediatr 31:267-275, 2010.
19. Logan S, Nicholas J, Carpenter LA, King LB, Garrett-Mayer E, Charles JM: High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network Ann Epidemiol 22:1-8, 2012.
20. Mandell D, Carpenter L, Daniels J, DiGuiseppi C, Durkin M, Giarelli E, Morrier M, Nichols J, Pinto-Martin J, Shattuck P, Thomas K, Yeargin-Allsopp M, Kirby R: Racial and ethnic disparities in the identification of children with autism spectrum disorders. Am J Public Health 99:493-498, 2009.
21. Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE: Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics 121:e441-448, 2008.
22. Martin A, Scahill L, Klin A, Volkmar FR: Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use. J Am Acad Child Adolesc Psychiatry 38:923-931, 1999.
23. Montes G, Halterman J, Magyar CI: Access to and satisfaction with school and community health services for US children with ASD. Pediatrics 124:S407-S413, 2009.
24. Moore T, Symons F: Adherence to behavioral and medical treatment recommendations by parents of children with autism spectrum disorders. J Autism Dev Disord 39:1173-1184, 2009.
25. Myers SM: The status of pharmacotherapy for autism spectrum disorders. Exp Opin Pharmacother 8:1579-1603, 2007.
26. Myers SM, Johnson CP, American Academy of Pediatrics Council on Children with Disabilities: Management of children with autism spectrum disorders. Pediatrics 120:1162-1182, 2007.
27. Nicholas J, Carpenter L, King L, Jenner W, Charles J: Autism spectrum disorders in preschool-aged children: Prevalence and comparison to a school-aged population. Ann Epidemiol 19:808-814, 2009.
28. Nicholas J, Carpenter L, King LB, Jenner W, Wahlquist A, Logan S, Charles JM: Completeness of case ascertainment for surveillance of autism spectrum disorders using the autism developmental disabilities monitoring network methodology. Disabil Health J 5:185-189, 2012.
29. Nicholas J, Charles J, Carpenter L, King L, Jenner W, Spratt E: Prevalence and characteristics of children with autism-spectrum disorders. Ann Epidemiol 18:130-136, 2008.
30. Pinborough-Zimmerman J, Satterfield R, Hossain S, McMahon W: The impact of surveillance method and record source on autism prevalence: Collaboration with Utah maternal and child health programs. Matern Child Health J 14:392-400, 2009.
31. Powell KC, Singh RH, Shapira SK, Olney RS, Yeargin-Allsopp M: Prevalence of developmental disabilities and receipt of special education services among children with an inborn error of metabolism. J Pediatr 156:420-426, 2010.
32. Rice CE, Baio J, Van Naarden Braun K, Doernberg N, Meaney FJ, Kirby RS; ADDM Network: A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol 21:179-190, 2007.
33. Riddle MA, Kastelic E, Frosch E: Pediatric psychoharmacology. J Child Psychol Psychiatry 42:73-90, 2001.
34. Rogers SJ. Laurie A: Evidence-based comprehensive treatments for early autism. J Clin Child Adolesc Psychol 37:8-38, 2008.
35. Rosenberg R, Mandell D, Farmer JE, Law JK, Marvin AR, Law PA: Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008. J Autism Dev Disord 40:342-351, 2009.
36. Rubin DM, Feudtner C, Localio R, Mandell DS: State variation in psychotropic medication use by foster care children with autism spectrum disorder. Pediatrics 124:e305-312, 2009.
37. Safer DJ, Zito J, Dos Reis S: Concomitant psychotropic medication for youths. Am J Psychiatry 160:438-449, 2003.
38. Shattuck P, Grosse S: Issues related to the diagnosis and treatment of autism spectrum disorders. Ment Retard Dev Disabil Res Rev 13:129-135, 2007.
39. Shattuck PT, Durkin M, Maenner M, Newschaffer C, Mandell DS, Wiggins L, Lee LC, Rice C, Giarelli E, Kirby R, Baio J, Pinto-Martin J, Cuniff C: Timing of identification among children with an autism spectrum disorder: Findings from a population-based surveillance study. J Am Acad Child Adolesc Psychiatry 48:474-483, 2009.
40. Spencer D, Marshall J, Post B, Kulakodlu M, Newschaffer C, Dennen T, Azocar F, Jain A: Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics 132:833-840, 2013.
41. Stevens J, Wang W, Fan L, Edwards MC, Campo JV, Gardner W: Parental attitudes towards children's use of antidepressant and psychotherapy. J Child Adolescent Psychopharmacol 19:289-296, 2009.
42. Van Naarden Braun K, Schieve L, Daniels J, Durkin M, Giarelli E, Kirby RS, Lee LC, Newschaffer C, Nicholas J, Pinto-Martin J: Relationships between multiple births and autism spectrum disorders, cerebral palsy, and intellectual disabilities: Autism and Developmental Disabilities Monitoring (ADDM) Network - 2002 Surveillance Year. Autism Res 1:265-316, 2008.
43. Wiggins LD, Baio J: Developmental regression in children with an autism spectrum disorder identified by a population-based surveillance system. Autism 13:357-374, 2009.
44. Yeargin-Allsopp M, Doernberg NS, Benedict RE, Kirby RS, Durkin MS: Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: A multisite collaboration. Pediatrics 121:547-554, 2008.
45. Yeargin-Allsopp M, Karapurkar T, Doernberg N, Boyle C, Murphy C: Prevalence of autism in a US metropolitan area. J Am Med Assoc 289:49-55, 2003.
46. Zito JM, Safer DJ, DosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA: Psychotropic practice patterns for youth: A 10-year perspective. Arch Pediatr Adolesc Med 157:17-25, 2003.